Characterization of stability, safety and immunogenicity of the mRNA lipid nanoparticle vaccine Iribovax® against COVID-19 in nonhuman primates

Parvin Zamani, Mohammad Mashreghi, Mahere Rezazade Bazaz, Selma Zargari, Farzaneh Alizadeh, Mahyar Dorrigiv, Asghar Abdoli, Hossein Aminianfar, Mahdi Hatamipour, Javad Zarqi, Saeed Behboodifar, Yalda Samsami, Saeideh Khorshid Sokhangouy, Yahya Sefidbakht, Vuk Uskoković, Seyed Mahdi Rezayat, Mahmoud Reza Jaafari, Sina Mozaffari‐Jovin